Wednesday, December 02, 2020 10:54:32 AM
RVVTF is a strong buy, seeking alpha article just out, it covers several biotechs including RVVTF at the opening of the article. I may buy more RVVTF.
This article is a good read for biotech investors!
Seems RVVTF has a second product in COVID19 trials now? Also mentions strong financial base of RVVTF. I am still reading it and other news.
https://seekingalpha.com/article/4392263-relief-therapeutics-covid-treatment-for-emergencies?utm_medium=email&utm_source=seeking_alpha&mail_subject=today-s-articles-on-global-investing&utm_campaign=nl-global-markets&utm_content=link-0
Giovanni, do you have the name of the blog paper from Medium you quoted, so I can get a full copy? Thanks for sharing the meat on that one.
Very interesting stuff as always!
This article is a good read for biotech investors!
Seems RVVTF has a second product in COVID19 trials now? Also mentions strong financial base of RVVTF. I am still reading it and other news.
https://seekingalpha.com/article/4392263-relief-therapeutics-covid-treatment-for-emergencies?utm_medium=email&utm_source=seeking_alpha&mail_subject=today-s-articles-on-global-investing&utm_campaign=nl-global-markets&utm_content=link-0
Giovanni, do you have the name of the blog paper from Medium you quoted, so I can get a full copy? Thanks for sharing the meat on that one.
Very interesting stuff as always!
All of my posts are strictly opinions and should not be considered to be facts, or investment advise. They are for entertainment purposes only.
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
